【SUNZEN 0148 交流专区】宏诚生科

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”) PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN, REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PRIVATE PLACEMENT”)
We refer to the announcements made on 17 October 2014, 20 October 2014, 21 October 2014 and 28 October 2014 in relation to the Private Placement (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of Sunzen, TA Securities wishes to announce that the Board has on 7 November 2014 (“Price-fixing Date”) fixed the issue price for the placement of 14,880,000 Placement Shares at RM0.36 per Placement Share (“Issue Price”). The Issue Price represents a discount of approximately RM0.0244 or 6.35% to the five (5)-day volume weighted average market price of the Sunzen Shares up to and including 6 November 2014, being the last market day immediately preceding the Price-fixing Date of RM0.3844 per Sunzen Share. This announcement is dated 7 November 2014.

icy97

Whether the corporate proposal involves the issuance of new type and new class of securities?	No
Types of corporate proposal	Private Placement
Details of corporate proposal	PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 IN SUNZEN BIOTECH BERHAD (“SUNZEN”), REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PRIVATE PLACEMENT”)
No. of shares issued under this corporate proposal	14,880,000
Issue price per share ($$)	MYR 0.360
Par Value ($$)	MYR 0.100
Latest issued and paid up share capital after the above corporate proposal in the following
Units	165,036,166
Currency	MYR 16,503,616.600
Listing Date	14/11/2014

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2014	30/09/2013	30/09/2014	30/09/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,461	8,980	26,782	25,707
2	Profit/(loss) before tax	85	1,227	783	2,794
3	Profit/(loss) for the period	8	1,042	552	2,355
4	Profit/(loss) attributable to ordinary equity holders of the parent	8	1,042	552	2,355
5	Basic earnings/(loss) per share (Subunit)	0.01	0.70	0.37	1.58
6	Proposed/Declared dividend per share (Subunit)	0.00	0.80	0.00	0.80
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.3000		0.2200

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “THE COMPANY”) - VALUATION OF NON-CURRENT ASSETS
In accordance with Rule 9.19(46) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Sunzen wishes to inform that Sunzen Corporation Sdn. Bhd., a wholly-owned subsidiary of the Company, has carried out a revaluation on its properties, as detailed hereunder, for the purpose of internal management/ accounting: Property Date of Valuation   Net Carrying Amount as at 5 June 2014 (RM) Market Value as at 5 June 2014 (RM) Surplus/ (Deficit) (RM) HSD 55014, PT 56433, Mukim of Klang, District of Petaling, State of Selangor Darul Ehsan, bearing postal address No. 16, Jalan Anggerik Mokara 31/61, Kota Kemuning Industrial Park, Seksyen 31, 40460 Shah Alam, Selangor Darul Ehsan 5 June 2014 1,658,187 3,700,000      2,041,813 GRN 99077, Lot 69289, Mukim and District Klang, State of Selangor Darul Ehsan, bearing postal address No. 13, Jalan Anggerik Mokara 31/61, Kota Kemuning Industrial Park, Seksyen 31, 40460 Shah Alam, Selangor Darul Ehsan 5 June 2014 6,650,764 12,000,000 5,349,236 GRN 99074, Lot 69288, Mukim and District Klang, State of Selangor Darul Ehsan, bearing postal address No. 11, Jalan Anggerik Mokara 31/61, Kota Kemuning Industrial Park, Seksyen 31, 40460 Shah Alam, Selangor Darul Ehsan 5 June 2014 5,841,944 12,000,000 6,158,056 Total: 14,150,895 27,700,000 13,549,105 The valuation of the above properties was conducted by Messrs. Raine & Horne International Zaki + Partners Sdn. Bhd. (“Valuer”). The Valuer has inspected the above properties on 5 June 2014. Revaluation Surplus The revaluation of the above properties resulted in a surplus of RM13,549,105. The Board of Directors of the Company has approved the incorporation of the revaluation surplus into the financial statements of the Company for the year ending 31 December 2014. Effect on Net Assets per share of the Group The surplus on revaluation, net of tax, of the above properties increased the net assets per share by RM0.083 for year-to-date ended 30 September 2014. Documents available for Inspection The valuation report is available for inspection at the Registered Office of the Company situated at 10th Floor, Menara Hap Seng, No. 1 & 3, Jalan P. Ramlee, 50250 Kuala Lumpur, during normal business hours for a period of 3 months from the date of this announcement. This announcement is dated 25 November 2014.

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR “THE COMPANY”) - VALUATION OF NON-CURRENT ASSETS
Further to the Company’s announcement on 25 November 2014, the Board of Directors of Sunzen is pleased to announce that based on the audited financial statements as at 31 December 2013, the revaluation surplus will increase the net asset per share of the group from RM0.2181 to RM0.3020.

APULA

SUNZEN BIOTECH BERHAD (0148)      

---

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD (“the Company”) - Acquisition of shares in Sunzen Eservices Sdn. Bhd.
The Board of Directors is pleased to announce that the Company had on 6 January 2015 acquired 100 ordinary shares of RM0.10 each in Sunzen Eservices Sdn. Bhd. (“SESB”) from Mr. Chang Teck Chee @ Chug Teck Chee and Mr. Phang Tong Eng, representing 100% of the total issued and paid-up share capital of SESB for a total cash consideration of RM10.00 (“Acquisition”). In consequence thereof, SESB shall become a wholly-owned subsidiary of the Company. The authorised share capital of SESB is RM400,000.00 divided into 4,000,000 ordinary shares of RM0.10 each and the paid-up capital is RM10.00 divided into 100 ordinary shares of RM0.10 each. The business activity of SESB is providing solutions in the areas of self-service machines and universal delivery systems and information technology services. The Directors of SESB are:- (a) Mr. Chang Teck Chee @ Chug Teck Chee; and (b) Mr. Phang Tong Eng. The Acquisition would not have material effect on the Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 December 2015. None of the Directors and/or Major Shareholders of the Company and/or persons connected to them has any interest, direct or indirect, in the Acquisition. This announcement is dated 6 January 2015.

icy97

宏诚生科2送1红股

财经新闻 财经  2015-01-23 11:38
（吉隆坡22日讯）宏诚生科（SUNZEN，0148，创业板）建议以2配1比例，派送最多1亿952万3280股红股，回馈股东。

配合红股派送活动，该公司也建议将注册股本，从2亿5000万股，扩大至5亿股。

宏诚生科表示，送红股活动将会动用股票溢价户头及保留盈利的资金。

如无意外，红股派送估计可在首季完成。【南洋网财经】

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	SUNZEN BIOTECH BERHAD (“SUNZEN” OR THE “COMPANY”) (I)        PROPOSED BONUS ISSUE OF SHARES; (II)        PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL; AND (III)        PROPOSED AMENDMENT
On behalf of the Board of Directors of Sunzen (“Board”), TA Securities Holdings Berhad (“TA Securities”) wishes to announce that the Company proposes to undertake the following: (i)          proposed bonus issue of up to 109,523,280 new ordinary shares of RM0.10 each in Sunzen (“Sunzen Shares”) (“Bonus Shares”) on the basis of one (1) Bonus Share for every two (2) existing Sunzen Shares held at an entitlement date to be determined later (“Entitlement Date”) (“Proposed Bonus Issue of Shares”); (ii)         proposed increase in the authorised share capital of Sunzen from RM25,000,000 comprising 250,000,000 Sunzen Shares to RM50,000,000 comprising 500,000,000 Sunzen Shares (“Proposed Increase in Authorised Share Capital”); and (iii)        proposed amendment to the Memorandum of Association of Sunzen to facilitate the Proposed Increase in Authorised Share Capital (“Proposed Amendment”). Please refer to the attachment for further details of the Proposals. This announcement is dated 22 January 2015. http://www.bursamalaysia.com/market/listed-companies/company-announcements/1859425

Attachments Sunzen - Announcement - Proposed Bonus Issue of Shares.final.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD (“the Company”) - Acquisition of shares in Sunzen International Investment Limited by Sunzen Eservices Sdn. Bhd., a wholly-owned subsidiary of the Company
The Board of Directors is pleased to announce that Sunzen Eservices Sdn. Bhd. (“SESB”), a wholly-owned subsidiary of the Company, had on 22 January 2015 acquired 100 ordinary shares in Sunzen International Investment Limited (“SIIL”) from Silk Nominees Limited, representing 100% of the total issued share capital of SIIL for a total cash consideration of HKD100 (“Acquisition”). In consequence thereof, SIIL shall become a wholly-owned subsidiary of SESB, which in turn is a wholly-owned subsidiary of the Company. SIIL was incorporated as a limited company in Hong Kong on 9 January 2015. The issued share capital of SIIL is HKD100 comprising 100 ordinary shares and the business activity of SIIL is investment and project management. The sole Director of SIIL is Mr Hong Choon Hau. The Acquisition would not have material effect on the Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 December 2015. None of the Directors and/or Major Shareholders of the Company and/or persons connected to them has any interest, direct or indirect, in the Acquisition. This announcement is dated 23 January 2015.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2014

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2014	31/12/2013	31/12/2014	31/12/2013
		$$'000	$$'000	$$'000	$$'000

1	Revenue	10,557	11,619	37,339	37,326
2	Profit/(loss) before tax	609	1,381	1,392	4,090
3	Profit/(loss) for the period	549	1,239	1,101	3,508
4	Profit/(loss) attributable to ordinary equity holders of the parent	549	1,239	1,101	3,508
5	Basic earnings/(loss) per share (Subunit)	0.33	0.83	0.66	2.35
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.80
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.3000		0.2200

icy97

Whether the corporate proposal involves the issuance of new type and new class of securities?	No
Types of corporate proposal	Others
Details of corporate proposal	Conversion of Warrants
No. of shares issued under this corporate proposal	14,274,700
Issue price per share ($$)	MYR 0.100
Par Value ($$)	MYR 0.100
Latest issued and paid up share capital after the above corporate proposal in the following
Units	187,662,935
Currency	MYR 18,766,293.500
Listing Date	07/04/2015

icy97

Type	Announcement
Subject	DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) DEALINGS OUTSIDE CLOSED PERIOD
Description	NOTIFICATION OF DEALINGS IN THE COMPANY’S SECURITIES OUTSIDE CLOSED PERIOD BY DIRECTOR PURSUANT TO RULE 14.09 OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD (“BURSA SECURITIES”)
We wish to announce that the Company has received notification from the following Director of the Company on his dealings in the securities of the Company outside closed period as defined in the Ace Market Listing Requirements of Bursa Securities as shown in the table below:- Name of Directors Date of Dealings Description of Securities Type of interest No. of Securities acquired/ (disposed) Percentage of securities acquired/ (disposed) Total no. of securities after acquired/ disposal Circumstances by reason of which change has occurred Hong Choon Hau 6.4.2015 Warrants Direct (12,000,000) (31.28%) Nil Conversion of Warrants Ordinary Shares 12,000,000 6.4% 53,046,000 This announcement is dated 10 April 2015

Name	Hong Choon Hau
Address	10, Jalan Margosa SD10/4C Bandar Sri Damansara 52200 Kuala Lumpur
NRIC/Passport No/Company No.	761113-02-5869
Nationality/Country of incorporation	Malaysian
Descriptions (Class & nominal value)	Ordinary shares of RM0.10 each
Name & address of registered holder	Maybank Securities Nominees (Tempatan) Sdn Bhd Maybank Kim Eng Securities Pte Ltd for Maybank Pte Ltd (A/C 649063) Level 5 Maybanlife Tower, Dataran Mayban 1 Jalan Maarof 59000 Kuala Lumpur

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Date of change	No of securities	Price Transacted (RM)
Others	06/04/2015	12,000,000

Description of other type of transaction	Conversion of Warrants
Circumstances by reason of which change has occurred	Conversion of Warrants
Nature of interest	Direct interest
Direct (units)	53,046,000
Direct (%)	28.29
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	53,046,000
Date of notice	13/04/2015

icy97

EX-date	29/04/2015
Entitlement date	05/05/2015
Entitlement time	05:00:00 PM
Entitlement subject	Bonus Issue
Entitlement description	BONUS ISSUE OF UP TO 109,523,280 NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN BIOTECH BERHAD (“SUNZEN”) (“SUNZEN SHARES”) (“BONUS SHARES”) ON THE BASIS OF ONE (1) BONUS SHARE FOR EVERY TWO (2) EXISTING SUNZEN SHARES HELD AS AT 5.00 P.M. ON 5 MAY 2015 (“ENTITLEMENT DATE”) (“BONUS ISSUE OF SHARES”)
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Symphony Share Registrars Sdn Bhd Level 6, Symphony House Pusat Dagangan Dana 1 Jalan PJU 1A/46 47301 Petaling Jaya Selangor Darul Ehsan Tel. no.: 03-7849 0777
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	05/05/2015
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	1 : 2

icy97

EX-date	29/04/2015
Entitlement date	05/05/2015
Entitlement time	05:00:00 PM
Entitlement subject	Others
Entitlement description	ADJUSTMENT TO THE NUMBER OF THE OUTSTANDING WARRANTS 2014/2019 IN SUNZEN BIOTECH BERHAD (“SUNZEN”) CONSTITUTED BY THE DEED POLL DATED 28 MARCH 2014 (“DEED POLL”) (“OUTSTANDING WARRANTS”) PURSUANT TO THE BONUS ISSUE OF UP TO 109,523,280 NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN (“SUNZEN SHARES” OR “SHARES”) (“BONUS SHARES”) ON THE BASIS OF ONE (1) BONUS SHARE FOR EVERY TWO (2) EXISTING SUNZEN SHARES HELD AS AT 5.00 P.M. ON 5 MAY 2015 (“ENTITLEMENT DATE”) (“BONUS ISSUE OF SHARES”)
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no	Symphony Share Registrars Sdn Bhd Level 6, Symphony House Pusat Dagangan Dana 1 Jalan PJU 1A/46 47301 Petaling Jaya Selangor Darul Ehsan Tel. no.: 03-7849 0777
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	05/05/2015
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	1 : 2
Rights Issues/Offer Price

Remarks :

Following the Bonus Issue of Shares, the exercise price and the number of Outstanding Warrants shall be adjusted in accordance with the provisions of the Deed Poll (“Adjustments”). Additional new Warrants 2014/2019 arising from the Adjustments (“Adjustment Warrants”) will be allotted and issued on the basis of one (1) Adjustment Warrant for every two (2) Outstanding Warrants held by the entitled holders of Outstanding Warrants of the Company, whose names appear in the Record of Depositors at 5.00 p.m. on the Entitlement Date. Any adjustments to the number of Outstanding Warrants will be rounded down to the nearest whole Warrant 2014/2019. No adjustment will be made to the existing exercise price of the Outstanding Warrants of RM0.10 each as the exercise price of the Outstanding Warrants cannot be adjusted below the par value of the Sunzen Shares of RM0.10 each. The actual number of Adjustment Warrants to be issued and allotted would depend on the number of Outstanding Warrants which have yet to be exercised into new Sunzen Shares as at the Entitlement Date. The Adjustment Warrants will be listed and quoted simultaneously with the Bonus Shares on the ACE Market of Bursa Securities on 6 May 2015, being the next market day following the Entitlement Date. The notice to the holders of Outstanding Warrants setting out the details of the Adjustments and the Adjustment Warrants to be issued pursuant to the Bonus Issue of Shares as well as the notice of allotment of the Adjustment Warrants will be despatched in due course. Holders of the Outstanding Warrants who wish to be entitled to the Bonus Shares pursuant to the Bonus Issue of Shares shall exercise their rights to subscribe for new Sunzen Shares by lodging their duly completed exercise forms together with the relevant subscription monies with Sunzen’s Share Registrar (at the address stated above) on or before 5.00 p.m. on 21 April 2015. This is to enable the new Sunzen Shares arising from such exercise to be allotted to the respective holders of the Outstanding Warrants such that their names will appear in the Record of Depositors for Sunzen Shares at 5.00 p.m. on the Entitlement Date. This announcement is dated 17 April 2015.

---

Announcement Info

Company Name	SUNZEN BIOTECH BERHAD (ACE Market)
Stock Name	SUNZEN-WA
Date Announced	17 Apr 2015
Category	Entitlements (Notice of Book Closure)
Reference No	OS-150417-38281

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) BONUS ISSUES
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR THE "COMPANY")BONUS ISSUE OF SHARES
We refer to our announcements dated 22 January 2015, 30 January 2015, 17 March 2015, 19 March 2015, 20 March 2015, 15 April 2015 and 17 April 2015 in relation to, amongst others, the Bonus Issue of Shares (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. Pursuant to Rule 6.36(4) of the ACE Market Listing Requirements of Bursa Securities, on behalf of the Board, TA Securities wishes to announce that 95,209,113 Bonus Shares and 11,729,986 Adjustment Warrants issued pursuant to the Bonus Issue of Shares will be listed and quoted on the ACE Market of Bursa Securities with effect from 9.00 a.m. on Wednesday, 6 May 2015. This announcement is dated 5 May 2015.

icy97

Instrument Category	Securities of PLC
Instrument Type	Warrants
Description	Adjustment to the number of the outstanding warrants 2014/2019 in Sunzen Biotech Berhad ("Sunzen") constituted by the deed poll dated 28 March 2014 ("Deed Poll") pursuant to the bonus issue of 95,209,113 new ordinary shares of RM0.10 each in Sunzen ("Sunzen Shares") ("Bonus Shares") on the basis of one (1) Bonus Share for every two (2) existing Sunzen Shares held as at 5.00 p.m. on 5 May 2015 ("Entitlement Date") ("Bonus Issue of Shares") ("Adjustment")

Listing Date	21 Apr 2014
Issue Date	15 Apr 2014
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Issue Size in Unit	61,486,246
Maturity	Mandatory
Maturity Date	14 Apr 2019
Revised Maturity Date
Name of Guarantor	Not Applicable
Name of Trustee	Not Applicable
Coupon/Profit/Interest/Payment Rate	Not Applicable
Coupon/Profit/Interest/Payment Frequency	Not Applicable
Redemption	Not Applicable
Exercise/Conversion Period	5.00   Year(s)
Revised Exercise/Conversion Period	Not Applicable
Exercise/Strike/Conversion Price	Malaysian Ringgit (MYR)   0.1000
Revised Exercise/Strike/Conversion Price	Not Applicable
Exercise/Conversion Ratio	1 : 1
Revised Exercise/Conversion Ratio	Not Applicable
Mode of satisfaction of Exercise/ Conversion price	Cash
Settlement Type/ Convertible into	Physical (Shares)

Remarks :

Pursuant to the Bonus Issue of Shares, 11,729,986 Adjustment Warrants will be listed and quoted on the ACE Market of Bursa Securities on 6 May 2015. However, no adjustment will be made to the existing exercise price of the Warrants 2014/2019 of RM0.10 each as the exercise price of the Outstanding Warrants cannot be adjusted below the par value of the Sunzen Shares of RM0.10 each.The notice to the holders of Outstanding Warrants setting out the details of the Adjustment and the Adjustment Warrants to be issued pursuant to the Bonus Issue of Shares as well as the notice of allotment of the Adjustment Warrants will be despatched in due course.This announcement is dated 5 May 2015.

---

Announcement Info

Company Name	SUNZEN BIOTECH BERHAD
Stock Name	SUNZEN-WA
Date Announced	05 May 2015
Category	Listing Information and Profile
Reference Number	LIP-05052015-00005

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2015	31 Mar 2014	31 Mar 2015	31 Mar 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,036	8,435	8,036	8,435
2	Profit/(loss) before tax	423	381	423	381
3	Profit/(loss) for the period	393	261	393	261
4	Profit/(loss) attributable to ordinary equity holders of the parent	393	261	393	261
5	Basic earnings/(loss) per share (Subunit)	0.23	0.17	0.23	0.17
6	Proposed/Declared dividend per share (Subunit)	0.00	0.80	0.00	0.80
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.3000		0.3000

icy97

宏诚携手Palma 联营脂肪粉贸易

财经新闻 财经  2015-06-18 10:53
（吉隆坡17日讯）宏诚生科（SUNZEN，0148，创业板）宣布，子公司Sunzen Feedtech私人有限公司与Palma科技产品私人有限公司缔结联营。

根据文告，双方今日签署协议，成立联营公司，从事脂肪粉（PowderFat）与其他产品的贸易与供应业务。

宏诚生科指出，这项联营计划可推动现有业务发展，并扩展更多商机。

Sunzen Feedtech与Palma科技产品，会分别以7万令吉和3万令吉，认购联营公司的7万股和3万股。

一旦完成交易，Sunzen Feedtech与Palma科技产品，将各别持有联营公司70%和30%股权。【南洋网财经】

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" or "the Company")- Joint Venture and Shareholders Agreement between Sunzen Feedtech Sdn. Bhd. and Palma Tech Product Sdn. Bhd.
The Board of Directors of Sunzen wishes to announce that on 17 June 2015, Sunzen Feedtech Sdn. Bhd. (Company No. 782887-K) (“SFSB”), a wholly-owned subsidiary of the Company, entered into a Joint Venture and Shareholders Agreement (“JVA”) with Palma Tech Product Sdn. Bhd. (Company No. 801562-H) (“PTP”) to form a new joint venture company (“JV Company”) to carry on trading and supplying the Powder Fat or such other products as may be determined by the parties pursuant to the JVA (“Products”) (“JV Business”). Please refer to thte attachment for the details of the announcement.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4775717

Attachments Attachment.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	SUNZEN BIOTECH BERHAD ("the Company" or "Sunzen")- Subscription of Shares in Sunzen Palma Sdn. Bhd. by Sunzen Feedtech Sdn. Bhd., a wholly-owned subsidiary of the Company
Reference is made to the Company’s announcements on 17 June 2015 and 18 June 2015 in relation to the Joint Venture and Shareholders’ Agreement between Sunzen Feedtech Sdn. Bhd. ("SFSB") and Palma Tech Product Sdn. Bhd. ("PTP") The Board of Directors of Sunzen wishes to announce that SFSB, a wholly-owned subsidiary of the Company, had on 29 June 2015 subscribed 70 ordinary shares of RM1.00 each, representing 70% equity interest in Sunzen Palma Sdn. Bhd. (Company No. 1150132-D) (“SPSB”) for a total cash consideration of RM70.00 (“Subscription”). In consequence thereof, SPSB shall become a 70%-owned subsidiary of SFSB. The authorised share capital of SPSB is RM400,000 divided into 400,000 ordinary shares of RM1.00 each and the issued and paid-up share capital is RM100 divided into 100 ordinary shares of RM1.00 each.  The business activity of SPSB is distribution and marketing of animal health products.The Board of Directors and Shareholders and their respective shareholdings in SPSB are as follows:- (I) Directors Hong Choon Hau; Lim Eng Chai; Liew Chu, Tsui Hung; and Ang Bee @ Ang Ah Bee. (II) Shareholders and their shareholdings a. SFSB – 70 ordinary shares of RM1.00 each (70%); and b. PTP - 30 ordinary shares of RM1.00 each (30%). None of the directors and/or major shareholders of the Company and/or persons connected with them have any interest, whether direct or indirect, in the Subscription. The Subscription would not have material effect on the Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 December 2015. This announcement is dated 30 June 2015.

icy97

宏诚执行董事辞职

财经新闻 财经  2015-08-06 10:04
（吉隆坡5日讯）宏诚生科（SUNZEN，0148，创业板）宣布，执行董事郭宝楚（译音）辞去现有职务。

根据文告，现任54岁的郭宝楚，以其它事项为由，辞去执行董事一职。

他拥有博特拉大学（UPM）兽医博士文凭，并在1998年和同事创办宏诚有限公司（Sunzen Corporation Sdn Bhd），买下美国辉瑞制药有限公司在大马的分销权。

目前，郭宝楚持有该公司434万3571股或1.5%股权。

宏诚有限公司于2007年改名为宏诚生科，并在2008年上市。【南洋网财经】

Date of change	03 Aug 2015
Name	DR KOK POE CHU
Age	54
Nationality	Malaysia
Designation	Executive Director
Directorate	Executive
Type of change	Resignation
Reason	Due to his other commitments
Details of any disagreement that he/she has with the Board of Directors	No
Whether there are any matters that need to be brought to the attention of shareholders	No
Qualifications	Dr. Kok holds a Doctor of Veterinary Medicine degree from University Putra Malaysia
Working experience and occupation	Dr. Kok has twenty seven years of industry experience and has worked for Gold Coin Feedmills (Singapore) Pte. Ltd. in Singapore and Ciba-Geigy Sdn. Bhd. dealing in livestock farming and animal nutrition. He was the Regional Product Manager for Pfizer Asean region from 1993 to 1997. In 1998, Dr. Kok together with other colleagues established Sunzen Corporation Sdn. Bhd. to undertake a management buy out of Pfizers local distribution and marketing operations. Dr. Kok was a member of the Malaysia Veterinary Council from 1997 to 2000. He held the post of Honorary Treasurer for the Veterinary Association of Malaysia in 1998 and was a volunteer veterinary officer of the National Nipah Virus Eradication Campaign for the DVS of the Ministry of Agriculture in 1999. He is currently an adviser to the Technical Advisory Committee of the Federal Livestock Farmers Association of Malaysia.
Family relationship with any director and/or major shareholder of the listed issuer	Nil
Any conflict of interests that he/she has with the listed issuer	Nil
Details of any interest in the securities of the listed issuer or its subsidiaries	Dr. Kok holds 4,343,571 ordinary shares in the Company